Internal Medicine (Preliminary)·Tulsa, OK

Oklahoma State University Center for Health Sciences

Allocate signal →Track an away here22-26 pooled · applicant-level
Step 2 invited
229–261
p10 – p90
Sample N
-
applicant rows
This cycle
-
no tracked aways yet
Match rate
-
no match data
No visa sponsorshipGraduated within 4 yearsDO recognizedCategoricalPreliminary
Your fitOklahoma State University Center for Health Sciences Program

Create a free profile to see your personalized fit

Get started

Who to contact

Training sites7 hospitals · Tulsa
  • 1
    Oklahoma State University Center for Health Sciences
    Tulsa, OK
    Primary
  • 2
    Hillcrest Medical Center
    Tulsa, OK
    Participant
  • 3
    Jack C Montgomery VA Medical Center
    Muskogee, OK
    Participant
  • 4
    Tulsa Cancer Institute
    Tulsa, OK
    Participant
  • 5
    Oklahoma Center for Arthritis Therapy & Research
    Tulsa, OK
    Participant
  • 6
    Oklahoma Heart Institute Southpointe
    Tulsa, OK
    Participant
  • 7
    Crawford Clinic
    Tulsa, OK
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK229 – 261
180205230255280
COMLEX Level 2 CE477 – 654
400500600700800
Interview rates
US MD
0%
US DO
18%
US IMG
0%
Non-US IMG
0%
Signal rates
Gold
28%
Silver
20%
None
8%
Applicant origin
In-state
22%
Out-of-state
12%
Interview prepInternal Medicine (Preliminary)
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Save this program

Add Oklahoma State University Center for Health Sciences to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Internal Medicine (Preliminary).

See how your profile compares across all programs.

Open calculator →

Program data, 2025 release. Not medical advice. © 2026 Rezumab LLC.